which is best semaglutide or tirzepatide vs Semaglutide vs. Tirzepatide: A Comparative

Tirzepatide has a half-life of approximately 5 days, allowing for a clean GLP-1 taper

A recent observational study saw tirzepatide outperform Novos semaglutide in helping patients to lose weight, and some analysts predict Lilly will indeed gain majority market share within a few years in part due to this potential efficacy advantage, though manufacturing is a complicating factor that currently favors Novo

Rare but serious adverse effects include pancreatitis (though causality remains uncertain), gallbladder disease, and potential thyroid C-cell tumors (observed in rodent studies but not conclusively demonstrated in humans)

Dpp4 inhibition as a therapeutic strategy in cardiometabolic disease: Incretin-dependent and -independent function

A separate regulatory status This is the major asymmetry between the two